BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34049801)

  • 1. MicroRNAs: Regulators of immunological reactions in hepatocellular carcinoma.
    Gupta M; Akhtar J; Sarwat M
    Semin Cell Dev Biol; 2022 Apr; 124():127-133. PubMed ID: 34049801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape.
    Han Q; Zhao H; Jiang Y; Yin C; Zhang J
    Cells; 2019 Jun; 8(6):. PubMed ID: 31181729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma.
    Rai V; Abdo J; Alsuwaidan AN; Agrawal S; Sharma P; Agrawal DK
    Mol Cell Biochem; 2018 Jan; 437(1-2):13-36. PubMed ID: 28593566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs involved with hepatocellular carcinoma (Review).
    Mao B; Wang G
    Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of miR-193a and sorafenib on hepatocellular carcinoma cells.
    Salvi A; Conde I; Abeni E; Arici B; Grossi I; Specchia C; Portolani N; Barlati S; De Petro G
    Mol Cancer; 2013 Dec; 12():162. PubMed ID: 24330766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
    Lamontagne J; Steel LF; Bouchard MJ
    World J Gastroenterol; 2015 Jun; 21(24):7375-99. PubMed ID: 26139985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
    Gailhouste L; Ochiya T
    Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The miR-561-5p/CX
    Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z
    Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.
    Su Z; Ye X; Shang L
    Yonsei Med J; 2019 Jan; 60(1):22-29. PubMed ID: 30554487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review.
    Zhao J; Wang Y; Su H; Su L
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101736. PubMed ID: 34146723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma.
    Li G; Cai G; Li D; Yin W
    Postgrad Med J; 2014 Feb; 90(1060):106-12. PubMed ID: 24243965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.
    Chen E; Xu X; Liu R; Liu T
    Biomed Res Int; 2018; 2018():6784607. PubMed ID: 29951542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.
    D'Anzeo M; Faloppi L; Scartozzi M; Giampieri R; Bianconi M; Del Prete M; Silvestris N; Cascinu S
    Molecules; 2014 May; 19(5):6393-406. PubMed ID: 24853455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
    Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
    Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review.
    Oura K; Morishita A; Masaki T
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications.
    Sun J; Lu H; Wang X; Jin H
    ScientificWorldJournal; 2013; 2013():924206. PubMed ID: 23431261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.